More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$756521992
EPS
1.15
P/E ratio
150
Price to sales
2.86
Dividend yield
0.475%
Beta
1.078218
Previous close
$134.09
Today's open
$133.03
Day's range
$133.03 - $135.93
52 week range
$69.51 - $144.35
show more
CEO
Gary Owens
Employees
717
Headquarters
LAKEWOOD, CO
Exchange
Nasdaq Global Select
Shares outstanding
5620520
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Mesa Laboratories, Inc. (MLAB) Q2 2027 Earnings Call Transcript
Mesa Laboratories, Inc. (MLAB) Q2 2027 Earnings Call Transcript
Seeking Alpha • Nov 10, 2026

What Mesa Laboratories (MLAB) Said on Its Q2 Earnings Call
Mesa Laboratories NASDAQ: MLAB reported higher revenue and earnings for its fiscal 2027 second quarter and issued full-year guidance, while outlining plans to restructure its Clinical Genomics business and repurchase up to $40 million in shares.
MarketBeat • Nov 10, 2026

Mesa Labs Announces Second Quarter Fiscal Year 2027 Results and Issues First Full-Year Guidance
LAKEWOOD, Colo., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced results for its second fiscal quarter (“2Q27”) ended September 30, 2026, and issued full-year guidance for the first time (dollars in thousands, except per-share amounts).
GlobeNewsWire • Nov 9, 2026

Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced it will release financial results for its second fiscal quarter (“2Q27”) ended September 30, 2026 following market close on Monday, November 9, 2026. The Company will also hold its earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
GlobeNewsWire • Oct 28, 2026

Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity
Utz Brands shares rose after entering into an agreement to be acquired by Intersnack, a privately held European leader in savory snacks. Shares of health care management company Astrana Health declined during the quarter as selling pressure emerged following a strong first half of 2026. We initiated a position in Bank7, given its highly profitable, branch-light model and recent acquisition of Century Bank, which we believe should meaningfully enhance earnings.
Seeking Alpha • Oct 28, 2026

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
LAKEWOOD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa,” “we,” “us” or “our”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced a savings plan (the “Savings Plan”) expected to reduce annualized operating costs by approximately $9.3 million.
GlobeNewsWire • Oct 13, 2026

Mesa Laboratories Q1 Earnings Call Highlights
Mesa Laboratories NASDAQ: MLAB reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control business and accelerate product development in Biopharmaceutical Development.
MarketBeat • Aug 11, 2026

Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
Seeking Alpha • Aug 11, 2026

Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
LAKEWOOD, Colo., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced it will release financial results for its first fiscal quarter (“1Q27”) ended June 30, 2026 following market close on Monday, August 10, 2026. The Company will also hold its first earnings conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
GlobeNewsWire • Aug 3, 2026

MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026.
GlobeNewsWire • Jul 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Mesa Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.